In contrast, the overexpression of IF1 in colon and breast carcinomas correlates with better patients’ prognosis16,53, stressing the importance and tissue-specific relevance of IF1 as a biomarker and target of cancer chemotherapy. This evidence concerns the gene ATP5IF1 and cancer.